ArticleEye (London, England)2023

Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)-a phase III, prospective, multicentre, randomized study: design and methods.

Leonard M Coulibaly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.